AKTX vs CELC
Akari Therapeutics, Plc · Celcuity Inc.
Relative return (rebased to 100)
Key stats
| Metric | AKTX | CELC |
|---|---|---|
| Price | $7.90 | $93.24 |
| Market Cap | $723.29B | $4.55B |
| P/E | — | — |
| P/B | 50298.18 | 84.95 |
| P/S | 1966113.15 | — |
| ROE | -120.3% | -330.8% |
| Net Margin | -4702.1% | — |
| Gross Margin | — | — |
| Revenue Growth | -39.5% | — |
| Dividend Yield | — | — |
| EPS | -$0.00 | -$3.63 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.